TRxADE HEALTH Balance Sheet Health
Financial Health criteria checks 1/6
TRxADE HEALTH has a total shareholder equity of $542.4K and total debt of $6.6M, which brings its debt-to-equity ratio to 1208.6%. Its total assets and total liabilities are $12.5M and $12.0M respectively.
Key information
1,208.6%
Debt to equity ratio
US$6.56m
Debt
| Interest coverage ratio | n/a |
| Cash | US$151.91k |
| Equity | US$542.35k |
| Total liabilities | US$11.99m |
| Total assets | US$12.53m |
Recent financial health updates
Recent updates
TRxADE Health prices of $1.8M stock offering
Oct 05TRxADE Health launches next day delivery services via Trxade prime plus program
Aug 30TRxADE Health proposes public stock offering
Aug 23Trxade Group GAAP EPS of -$0.13 misses by $0.05, revenue of $3.3M beats by $0.37M
Jul 25Will TRxADE HEALTH (NASDAQ:MEDS) Spend Its Cash Wisely?
Mar 30
Here's Why We're Watching TRxADE HEALTH's (NASDAQ:MEDS) Cash Burn Situation
Nov 23Need To Know: Analysts Just Made A Substantial Cut To Their TRxADE HEALTH, Inc. (NASDAQ:MEDS) Estimates
Jul 29Pharma Pain Points - Trxade CEO Suren Ajjarapu (Video)
Jun 16SpartanNash and Bonum Health join hands to provide telemedicine services
Jun 07Shareholders Will Probably Hold Off On Increasing Trxade Group, Inc.'s (NASDAQ:MEDS) CEO Compensation For The Time Being
May 22Earnings Release: Here's Why Analysts Cut Their Trxade Group, Inc. (NASDAQ:MEDS) Price Target To US$10.00
Apr 28Time To Worry? Analysts Just Downgraded Their Trxade Group, Inc. (NASDAQ:MEDS) Outlook
Apr 01Did Business Growth Power Trxade Group's (NASDAQ:MEDS) Share Price Gain of 143%?
Feb 05Financial Position Analysis
Short Term Liabilities: MEDS's short term assets ($2.8M) do not cover its short term liabilities ($11.6M).
Long Term Liabilities: MEDS's short term assets ($2.8M) exceed its long term liabilities ($434.2K).
Debt to Equity History and Analysis
Debt Level: MEDS's net debt to equity ratio (1180.6%) is considered high.
Reducing Debt: MEDS's debt to equity ratio has increased from 99.9% to 1208.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MEDS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: MEDS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 32.7% each year